(Q36627988)

15 August 2017

title

Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia? (English)

1 reference

15 August 2017

0 references

Kanapathippillai Karunakaran

series ordinal

1

1 reference

15 August 2017

Tongeji E Tungaraza

series ordinal

2

1 reference

15 August 2017

Giles C Harborne

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

18 October 2006

1 reference

Journal of Psychopharmacology

15 August 2017

published in

1 reference

15 August 2017

volume

21

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

453-456

1 reference

Partial agonism and schizophrenia

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Management of treatment resistance in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Possible increased efficacy of low-dose clozapine when combined with aripiprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

An overview of the central control of weight regulation and the effect of antipsychotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

Augmentation strategies in clozapine-resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106068289

21 January 2018

Identifiers

DOI

10.1177/0269881106068289

1 reference

15 August 2017

1 reference